Windtree Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$5.29 |
Market Cap |
$136 M |
Shares Outstanding |
32.13 M |
Public Float |
6.57 M |
Address |
2600 Kelly Road Warrington Pennsylvania 18976 United States |
Employees | - |
Website | http://www.windtreetx.com |
Updated | 07/08/2019 |
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. |